Previous Article | Next Article 
Journal of Virology, September 1999, p. 7218-7230, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Deletion of the R78 G Protein-Coupled Receptor
Gene from Rat Cytomegalovirus Results in an Attenuated,
Syncytium-Inducing Mutant Strain
Patrick S.
Beisser,
Gert
Grauls,
Cathrien A.
Bruggeman, and
Cornelis
Vink*
Department of Medical Microbiology,
Cardiovascular Research Institute Maastricht, Maastricht
University, 6202 AZ Maastricht, The Netherlands
Received 22 January 1999/Accepted 20 May 1999
 |
ABSTRACT |
The rat cytomegalovirus (RCMV) R78 gene belongs to an
uncharacterized class of viral G protein-coupled receptor (GCR) genes. The predicted amino acid sequence of the R78 open reading frame (ORF)
shows 25 and 20% similarity with the gene products of murine cytomegalovirus M78 and human cytomegalovirus UL78, respectively. The
R78 gene is transcribed throughout the early and late phases of
infection in rat embryo fibroblasts (REF) in vitro. Transcription of
R78 was found to result in three different mRNAs: (i) a 1.8-kb mRNA
containing the R78 sequence, (ii) a 3.7-kb mRNA containing both R77 and
R78 sequences, and (iii) a 5.7-kb mRNA containing at least ORF R77 and
ORF R78 sequences. To investigate the function of the R78 gene, we
generated two different recombinant virus strains: an RCMV R78 null
mutant (RCMV
R78a) and an RCMV mutant encoding a GCR from which the
putative intracellular C terminus has been deleted (RCMV
R78c). These
recombinant viruses replicated with a 10- to 100-fold-lower efficiency
than wild-type (wt) virus in vitro. Interestingly, unlike wt
virus-infected REF, REF infected with the recombinants develop a
syncytium-like appearance. A striking difference between wt and
recombinant viruses was also seen in vivo: a considerably higher
survival was seen among recombinant virus-infected rats than among
RCMV-infected rats. We conclude that the RCMV R78 gene encodes a novel
GCR-like polypeptide that plays an important role in both RCMV
replication in vitro and the pathogenesis of viral infection in vivo.
 |
INTRODUCTION |
G protein-coupled receptors (GCRs)
play a key role in transduction of extracellular signals to the
intracellular environment. They can be activated by a variety of
stimuli, such as neurotransmitters, hormones, and photons (reviewed by
Probst et al. [53]). Upon ligand binding, GCRs
activate G proteins, which in turn activate effector enzymes and ion
channels in a cascade-like fashion. Thousands of GCR variants are
encoded by genes of both prokaryotes and eukaryotes. Additionally, some
are encoded by virus genes. To date, 20 putative viral GCR genes have
been discovered: 2 in poxvirus genomes (21, 44), 11 in
betaherpesvirus genomes (9, 22, 33, 49, 54), and 7 in
gammaherpesvirus genomes (4, 26, 48, 57, 63). The majority
of these genes was found to be similar to genes encoding cellular
chemokine receptors. Although the functions of most of the putative
viral GCRs are unclear, several are capable of binding chemokines,
hence invoking a classical signal transduction response (1, 4, 31,
38, 42, 47). The herpesvirus saimiri (HVS) ECRF3-encoded
chemokine receptor is capable of transducing signals upon activation by
chemokines (1). The human cytomegalovirus (HCMV)
US28-encoded chemokine receptor was shown to be a promiscuous calcium-mobilizing receptor for several
chemokines (31).
Additionally, the US28 protein was suggested to be responsible for
-chemokine sequestration in HCMV-infected fibroblasts
(15). The GCR encoded by Kaposi's sarcoma-associated
herpesvirus (KSHV) open reading frame (ORF) 74 not only binds both
and
chemokines but also is constitutively active, inducing
second-messenger signalling in vitro (4). The KSHV chemokine
receptor was also shown to stimulate cellular proliferation
(4), transformation, and angiogenesis (7). A
distinctive set of chemokine-like receptors is exclusively encoded by
betaherpesviruses: HCMV UL33 (23), rat cytomegalovirus (RCMV) R33 (9), murine cytomegalovirus (MCMV) M33
(54), and human herpesvirus 6 and 7 (HHV-6 and -7) U12
(33, 49). Recently, we found that the RCMV R33 gene is
essential for the pathogenesis of viral infection in vivo and that
unlike wild-type (wt) virus, an RCMV R33 null mutant could neither
enter nor replicate in salivary gland epithelial cells of infected rats
(9). A similar observation was made for MCMV M33: upon
infection of mice with an MCMV M33 deletion mutant strain, virus could
not be recovered from mouse salivary glands (26).
Interestingly, betaherpesviruses encode another distinctive set of yet
uncharacterized viral GCRs: HCMV UL78 (22), MCMV M78
(54), and HHV-6 and -7 U51 (33, 49). Although the
positions of these UL78-like genes within the betaherpesvirus genomes
are conserved, their sequences are rather divergent. Despite the
presence of distinct GCR characteristics, such as seven transmembrane domains, two conserved cysteine residues, and a G protein-coupling domain (53), these UL78-like gene products show little
similarity with any of the thousands of GCRs known to date.
Nevertheless, characterization of this unique family of GCRs may be
crucial to the development of new antiviral therapeutics. In this
report, we present the sequence and transcriptional analysis of the
RCMV member of this family of GCR genes, which we termed R78. In
addition, RCMV strains were generated in which the R78 (ORF) is either
partially or completely deleted from the genome (RCMV
R78a or
RCMV
R78c, respectively). We show that disruption of the R78 gene
affects RCMV replication in permissive cell types in vitro and that the RCMV R78 deletion mutant strains induce syncytium formation in rat
embryo fibroblasts (REF) in vitro, in contrast to wt RCMV. In addition,
a dramatically lower mortality was observed in rats infected with
either RCMV
R78a or RCMV
R78c than in wt RCMV-infected rats. We
conclude that the RCMV R78 gene plays a vital role in both RCMV
replication in vitro and the pathogenesis of viral infection in vivo.
 |
MATERIALS AND METHODS |
Cells and virus.
Primary REF, rat fibroblast cell line Rat2
TK
(ATCC CRL 1764), rat heart endothelium cell line 116 (RHEC), monocyte/macrophage cell line R2 (R2M
), and rat aorta medial
smooth muscle cells (RSMC) were cultured as described previously
(18, 24, 50, 60). RCMV (Maastricht strain) was propagated in
REF (18). Virus titers were determined by a plaque assay
using standard procedures (19). RCMV DNA was isolated from
culture medium as described by Vink et al. (61).
Identification, cloning, and sequence analysis of the RCMV R78
gene.
Cloning of the 30-kb XbaI B fragment of the RCMV
genome into vector pSP62-PL has previously been described
(45). The XbaI B fragment was digested with
various restriction endonucleases, and the resulting fragments were
cloned into vector pUC119. Both strands of each clone were sequenced by
using the Cy5 Autoread sequencing kit (Pharmacia Biotech, Roosendaal,
The Netherlands) and ALFexpress automated DNA sequencer (Pharmacia
Biotech). Sequence analysis was done with the program PC/Gene (version
2.11; IntelliGenetics). The sequences were checked for the presence of
HCMV UL78-homologous regions by alignment with the GenBank nucleic acid
database, using the BLASTN search algorithm (39). Thus, a
3.7-kb BamHI fragment was identified, which contains an ORF
with considerable similarity to the HCMV UL78 ORF.
RCMV
R78a recombination plasmid construction.
Plasmid
p115, which contains a large part of the R78 ORF on a 2.4-kb
SalI fragment (Fig. 1), was
digested with SalI and subsequently treated with
deoxynucleotide triphosphates and DNA polymerase I Klenow fragment
(Pharmacia Biotech). Subsequently, the DNA was digested with
BglII, and the resulting 1.4-kb fragment was cloned into
BamHI-SmaI-treated vector pUC119, generating
plasmid pA. Plasmid p114, which contains the remaining part of the R78
ORF on a 1.7-kb SalI fragment (Fig. 1), was digested with
SalI. The 1.7-kb SalI insert from p114 was
ligated into the SalI site of pA, generating pB. A 1.5-kb
BamHI-EcoRI fragment from Rc/CMV (Invitrogen, Leek, The Netherlands), containing the neomycin resistance
(neo) gene, was treated with Klenow enzyme and ligated into
a XbaI-digested and Klenow enzyme-treated vector pB. This
final construct (p147 [see Fig. 4]) was linearized by digestion with
Asp718I and HindIII and used for
transfection, in order to generate mutant RCMV
R78a.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Restriction map of the RCMV genome and relative position
of the R78 gene, which encodes a putative GCR. An enlarged section of
the map is shown below. Arrow boxes indicate the size and polarity of
conserved RCMV ORFs.
|
|
RCMV
R78c recombination plasmid construction.
Plasmid
p116, which contains the complete R78 ORF on a 3.7-kb BamHI
fragment (Fig. 1), was digested with Asp718I and
NcoI. The resulting 2.9-kb fragment was treated with Klenow
enzyme and subsequently circularized with T4 DNA ligase, resulting in
plasmid pC. One SalI site was removed from pC by digestion
of the plasmid with XbaI and HindIII and
subsequent treatment with Klenow enzyme. The resulting fragment was
circularized, generating plasmid, pD. Plasmid pD was digested with
SalI, treated with Klenow enzyme, and ligated to the
blunt-ended DNA fragment containing the Rc/CMV neo gene (see
above). The resulting plasmid, p120 (see Fig. 4), was linearized with
Asp718I and XbaI prior to transfection, in order
to generate mutant RCMV
R78c.
Generation of RCMV R78 deletion mutants.
Approximately
107 Rat2 cells were trypsinized and subsequently
centrifuged for 5 min at 500 × g. The cells were
resuspended in 0.25 ml of culture medium, after which 10 µg of
linearized plasmid of either p120 or p147 was added. The suspension was
transferred to a 0.4-cm electroporation cuvette (Bio-Rad, Veenendaal,
The Netherlands) and pulsed at 0.25 kV and 500 µF in a Bio-Rad Gene Pulser electroporator. The cells were subsequently seeded in
10-cm-diameter culture dishes. At 6 h after transfection, the
cells were infected with RCMV at a multiplicity of infection (MOI) of
1. The culture medium was supplemented with 50 µg of G418 per ml at
16 h postinfection (p.i.). Recombinant viruses were plaque
purified and cultured on REF monolayers as described earlier
(9).
Southern blot hybridization.
DNA was isolated from wt RCMV,
RCMV
R78a, and RCMV
R78c and then digested with either
BamHI, BamHI-BglII,
BamHI-EcoRV, BamHI-NcoI, SalI, or SalI-EcoRV. Subsequently, the
digested DNA was electrophoresed through a 1% agarose gel and blotted
onto a Hybond N+ nylon membrane (Amersham,
's-Hertogenbosch, The Netherlands) as described previously
(16). Both a 3.7-kb insert from p116 containing the intact
R78 ORF as well as sequences from R77 and R79 (R78 probe [see Fig.
5A]), along with a 1.5-kb BamHI-EcoRI fragment
containing the neo gene (neo probe) from Rc/CMV, were used
as probes. Hybridization and detection experiments were performed with
digoxigenin DNA labeling and chemiluminescence detection kits
(Boehringer Mannheim, Almere, The Netherlands).
Isolation of poly(A)+ RNA and Northern blot
analysis.
RCMV poly(A)+ RNA was isolated from REF at
2, 8, and 48 h p.i. and at immediate-early (IE), early (E), and
late (L) times of infection with RCMV (MOI = 1). To obtain IE
mRNA, REF were treated with 100 µg of cycloheximide per ml 1 h
before, during, and 16 h after infection. During the 1-h infection
period, the cells were exposed to RCMV. E mRNA was isolated after
infection of REF with RCMV and treatment of cells with 100 µg of
phosphonoacetic acid per ml from 3 h p.i. until the cells were
harvested at 13 h p.i. L mRNA was isolated after infection of REF
with either RCMV, RCMV
R78a, or RCMV
R78c and harvesting of cells
at 72 h p.i. To obtain mRNA from mock-infected cells, a procedure
similar to that described for the purification of L mRNA was used
except that RCMV infection was omitted. Poly(A)+ RNA was
purified with a QuickPrep Micro mRNA purification kit (Pharmacia
Biotech). Aliquots (1 µg) of poly(A)+ RNA were
electrophoresed through agarose under denaturing conditions as
described by Brown and Mackey (17); then the RNA was
transferred to positively charged nylon membranes (Boehringer Mannheim)
as described previously (17). The 754-bp
BamHI-SalI fragment from p115 and the 950-bp
BglII-SalI, 206-bp
BglII-NarI, and 1,088-bp BglII-SalI fragments from p116 (see Fig. 6A) were
used to generate probes. These fragments contain R77-, R78-, R79-, and
R79/R80-specific sequences, respectively. Hybridization and detection
experiments were performed with digoxigenin DNA labeling and
chemiluminescence detection kits (Boehringer Mannheim).
Replication of
R78a and
R78c in vitro.
REF, RHEC,
R2M
, and RSMC were grown either in 96-well plates or on glass slides
and infected with either RCMV, RCMV
R78a, or RCMV
R78c at an MOI of
0.1 or 1. Culture medium samples (three per virus) were taken at 1, 3, 5, and 7 days p.i. and subjected to plaque titer determination. The
cells were fixed and stained with monoclonal antibodies (MAbs) against
RCMV E proteins (MAb RCMV 8 [20]) as described
previously (60). The degree of infection was determined by
counting the number of antigen-positive cells relative to the total
number of cells in three different wells (four microscopic fields per
well at a magnification of ×400).
Dissemination of wt RCMV and RCMV
R78c in vivo.
Male
specific-pathogen-free Lewis/N RT1 rats (Central Animal Facility,
Maastricht University, Maastricht, The Netherlands), used for all in
vivo experiments in this study, were kept under standard conditions
(55). Rats were immunocompromised by 5 Gy of total-body
Röntgen irradiation 1 day before infection as described by Stals
et al. (55), and all virus stocks that were used for inoculation in vivo were derived from tissue culture medium of virus-infected REF. Two groups of rats (10 weeks old; body weight of
250 to 300 g) were infected with 5 × 106 PFU of
either RCMV or RCMV
R78c. On days 4 and 21 p.i., five rats from
each group were sacrificed, and their internal organs were collected.
These organs were subjected to both plaque assay and
immunohistochemistry (19). Tissue sections (4 µm) of the submaxillary salivary gland, spleen, kidney, liver, lung, heart, pancreas, thymus, aorta, and cervical lymph nodes were stained with MAb
RCMV 8.
Survival of immunocompromised rats infected with either RCMV,
RCMV
R78a, or RCMV
R78c.
Four-week-old rats (100 to 120 g) were divided into three groups of five rats. Intraperitoneal
infection was carried out with 106 PFU of either RCMV,
RCMV
R78a, or RCMV
R78c. The number of surviving rats was recorded
daily until day 28 p.i.
Nucleotide sequence accession number.
The nucleotide
sequence of the 3.7-kb BamHI fragment containing the R78
gene (Fig. 1) and the predicted amino acid sequence derived from R78
have been deposited in the GenBank database under accession no.
AF077758.
 |
RESULTS |
Identification, cloning, and sequence analysis of the RCMV R78
gene.
Previously, it was shown that the majority of RCMV genes are
collinear with genes of both HCMV and MCMV (9-11, 61, 62). We hypothesized that the position of a putative RCMV UL78 homolog would
be analogous to that of both HCMV UL78 (22) and MCMV M78 (54). Accordingly, we focused on the 33-kb RCMV
XbaI B fragment (Fig. 1) (45). This fragment was
digested with various restriction endonucleases, subcloned, and
sequenced. The GenBank database was subsequently screened for homology
with the generated sequence. Thus, we identified (in plasmid p116) a
3.7-kb BamHI fragment showing considerable similarity to a
region within the genomes of HCMV as well as MCMV, containing the UL78
and M78 genes, respectively. A 1,422-bp ORF was identified within the
BamHI fragment (Fig. 1), which has the potential to encode a
474-amino-acid polypeptide with a predicted molecular mass of 50 kDa.
This polypeptide shows 25 and 20% similarity with the amino acid
sequences of M78 (54) and UL78 (22), respectively
(Table 1). This low level of similarity is not uncommon to UL78-like sequences, since the amino acid sequences derived from UL78 and M78 share only 21% similarity (Table 1). In
analogy to the nomenclature for the corresponding HCMV and MCMV genes,
the 1,422-bp RCMV ORF was termed R78.
To investigate whether the amino acid sequence of the R78-derived
polypeptide (pR78) possesses features that are characteristic
of GCRs,
the pR78 sequence was analyzed with computer program
TMpred (ISREC
Bioinformatics Group, Epalinges, Switzerland [
58]).
This program utilizes a database of existing transmembrane domains
to
predict potential transmembrane domains of an uncharacterized
sequence.
Computation revealed an extracellular N terminus and
eight
transmembrane domains, each of which might be folded as
an

helix.
Seven of these domains are collinear with the predicted
transmembrane
domains of the gene products of MCMV M78 and HCMV
UL78 (Fig.
2). In addition, several amino acid
residues that are
conserved among most GCRs were identified (reviewed
by Probst
et al. [
53]): two conserved cysteine
residues at positions 94
and 190, which may form a disulfide bridge,
and a conserved aspartic
acid-arginine-leucine (DRL) motif (positions
118 to 120) that
might be involved in G protein coupling (Fig.
2).
These residues
are also present within analogous regions of the UL78
and M78
gene products and the HHV-6 and -7 U51 gene products (Fig.
2).
Another interesting feature is the presence of a putative tyrosine
kinase phosphorylation site (phosphorylation consensus
[R/K]X
2/3[D/E]X
2/3Y,
at positions 392 to
400) (Fig.
2). These putative tyrosine phosphorylation
sites are found
in the predicted amino acid sequences of RCMV
R78, MCMV M78, and HCMV
UL78 but not in analogous regions of the
predicted U51 amino acid
sequence of either HHV-6 or HHV-7 (Fig.
2).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 2.
Schematic representation of the gene products of RCMV
R78, MCMV M78, HCMV UL78, and HHV-6 and -7 U51. The top drawing shows
the two-dimensional orientation of GCRs (not to scale with diagrams of
the other GCRs). Horizontal lines represent the one-dimensional
structure of the R78-like gene products; designations of the genes that
encode these receptors are shown at the left. Black boxes represent
putative transmembrane helices; the white box indicates an
additional unique hydrophobic -helix domain predicted by the
computer program TMpred (58); the hatched box indicates a
hydrophobic stretch of amino acid residues collinear with predicted
transmembrane domains of the other GCRs, although not predicted by
TMpred. Conserved cysteine residues are indicated by C's. The
(D/E)R(I/L) motifs indicate positions of the conserved putative G
protein-coupling domains. The sequences enclosed in white boxes
indicate positions of putative tyrosine kinase phosphorylation sites
that are conserved among CMV genes relative to R78.
|
|
In order to classify the GCRs encoded by the R78-like genes, the
predicted amino acid sequences of R78, M78, UL78, and HHV-6
and -7 U51
were screened against a nonredundant protein sequence
data set (a
combination of all nonredundant GenBank complete protein
coding gene
translations plus sequences from the Protein Data
Bank, SwissProt, and
Protein Information Resource databases [
39]).
This
analysis demonstrated a clear relationship between pR78-like
peptides
and other GCRs; the predicted amino acid sequence of
the UL78 gene was
similar to sequences of GCRs such as a thrombin
receptor
(
32) and opioid receptor (
66), while the M78 gene
product shows similarity with a lysophosphatidic acid receptor
(
3) and a somatostatin-like receptor (
64).
Surprisingly,
the sequence of the C-terminal part of the R78 gene
product was
found to be similar to collagen-like sequences (in
particular
sequences such as human collagen (
51) and spider
silk protein
(
65). Although previously examined
virus-encoded GCRs were shown
to be related to chemokine receptors
(
1,
4,
9,
21,
26,
30,
38,
42,
44,
47,
57,
63), none of the
pR78-like
GCRs showed a collective similarity with GCRs of any
particular
class. Most notably, the N-terminal part of the R78-like
gene
products lack the signals for N-linked glycosylation, which are
present in the N-terminal sequences of all other known virus-encoded
GCRs, making this a unique set of receptors among virus-encoded
GCRs.
R78 transcription.
Although the ORFs of R78-like
betaherpesvirus genes are poorly conserved, they are all preceded by a
remarkable double TATA signal motif. Moreover, the start codons of R78,
M78, and UL78 conform to the Kozak consensus (41). The
positions and sequences of these motifs are summarized in Table
2. We set out to identify transcripts
derived from the RCMV R78 gene by Northern blot analysis. As shown in
Fig. 3, R78-specific hybridization
signals were detected in phosphonoacetic acid-treated (lane 3) and
untreated (lane 4) cells but not in cycloheximide-treated (lane 2) or
mock-infected (lane 1) cells. In untreated, RCMV-infected REF,
R78-specific signals were detected at 8 and 48 h p.i. (lanes 7 and
8, respectively) but not at earlier time points (lane 5 and 6, respectively). These results classify R78 as an E gene that is also
transcribed during the L phase of infection in vitro.

View larger version (77K):
[in this window]
[in a new window]
|
FIG. 3.
The RCMV R78 gene is transcribed at both E and L times
of infection in REF. Lanes 1 and 5 of the autoradiograph of a Northern
blot hybridized with an R78-specific probe represent mRNA from
mock-infected (M) cells. Lanes 2 to 4 represent the IE, E, and L phases
of infection, respectively; lanes 6 to 8 represent transcripts from REF
at 2, 8, and 48 h p.i., respectively. The estimated lengths of the
different transcripts are indicated at the right in kilobases.
|
|
An R78-specific transcript with a length of approximately 1.8 kb was
detected during both the E and L phases (Fig.
3, lanes
3, 4, 7, and 8).
Since the R78 ORF was found to comprise 1,422
bp, and a putative
polyadenylation signal (AATAAA) is located
94 bp downstream of the R78
ORF, we postulate that the 1.8-kb
transcript corresponds to an mRNA
that exclusively contains the
R78 ORF. Two other R78-specific
transcripts (3.7 and 5.7 kb, respectively)
were detected during the L
phase (lane 4) and at 48 h p.i. (lane
8). At 8 h p.i., we
detected a 3.9-kb transcript (lane 7) but
not the 3.7-kb transcript. It
is possible that early after infection
the combined transcription of
R77 and R78 is initiated at a location
0.2 kb upstream of the
transcription start site of the 3.7-kb
transcript. Alternatively, since
we did not use strand-specific
probes, the 3.9-kb transcript could have
derived from the opposite
strand of the R77/R78 locus. However, this
was not investigated
further. The 3.9- and 3.7-kb transcripts may
contain the R78 ORF
as well as one or more neighboring ORFs. This
hypothesis is supported
by the notion that the gene upstream of R78
(R77; see below) lacks
a polyadenylation site at its 3' end. Additional
Northern blot
hybridization data (shown below) support the hypothesis
of cotranscription
of R77, R78, and other RCMV
genes.
Generation of RCMV strains with a deletion of the R78 gene.
To
investigate the role of R78 in the pathogenesis of RCMV disease, we
constructed a mutant RCMV strain (RCMV
R78a) in which a 1,030-bp
BglII-SalI fragment from the R78 gene was deleted
and replaced with a 1.5-kb neo expression cassette (Fig.
4). Another RCMV mutant strain
(RCMV
R78c) was constructed such that an 80-bp SalI
fragment was replaced by the neo cassette (Fig. 4).
Consequently, the part of R78 that encodes the putative intracellular C
terminus was deleted and replaced by an irrelevant sequence of similar length, while the part that encodes the N terminus (including the seven
predicted transmembrane helices) was preserved (Fig. 4). The
deletion/insertion mutations were first introduced into plasmids
containing the R78 gene (Fig. 4). The R78 gene within the RCMV genome
was subsequently replaced by either of the mutated R78 genes via
homologous recombination, after transfection of fibroblasts with the
recombination plasmids and infection with RCMV. Selection for
recombinant strains was established by supplementing the growth medium
with G418. After plaque purification of the virus, the purity and
integrity of the recombinant strains were checked by Southern blot
analysis. Virion DNA from RCMV, RCMV
R78a, and RCMV
R78c was
purified and digested with BamHI-NcoI (Fig. 5). We also digested purified virion DNA
with either BamHI, BamHI-BglII, BamHI-EcoRV, NcoI, SalI, or
SalI-EcoRV (data not shown). After agarose gel
electrophoresis and transfer of the DNA to a filter, hybridization was
done with either an R78-specific probe or a neo-specific
probe. As shown in Fig. 5, the observed hybridization signals
correspond exactly to the predicted restriction fragments. In addition,
contaminating wt virus fragments were not detected in the RCMV
R78a
and RCMV
R78c lanes (Fig. 5). These findings indicated that both
recombinant strains are pure and contain the appropriate mutations.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 4.
Construction of RCMV strains in which the R78 gene is
disrupted. The RCMV genome, of which a segment representing the R78
region is shown in the middle, was modified by homologous recombination
with different recombination plasmids (p147 [top] or p120
[bottom]), resulting in RCMV R78a or RCMV R78c, respectively.
Approximately 85% of the R78 ORF has been deleted in the RCMV R78a
genome (resulting in a gene encoding only the N-terminal part including
half of the first predicted transmembrane domain, shown at the top
right). In mutant RCMV R78c, the part of the R78 that encodes the
putative intracellular C terminus has been replaced by a sequence
encoding a stretch of 97 amino acids of irrelevant sequence (bottom
right, indicated as a black arrow box). ORFs are shown as arrow boxes.
Wild-type and mutated R78 ORFs are indicated with descending hatches.
The neo genes that were inserted in the recombination
plasmids are indicated with ascending hatches.
|
|

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 5.
Southern blot analysis of recombinant viruses
RCMV R78a and RCMV R78c. (A) DNA from RCMV, RCMV R78a, and
RCMV R78c was digested with BamHI and NcoI,
electrophoresed, blotted, and hybridized with either a probe derived
from the p116 insert or a neo probe (both indicated with
black boxes). ORFs are shown as arrow boxes. Wild-type and mutated R78
ORFs are indicated by descending hatches. The neo genes that
were inserted in the recombination plasmids are indicated by ascending
hatches. (B) Autoluminograph of a Southern blot containing wt (w) DNA,
RCMV R78a (a) DNA, and RCMV R78c (c) DNA. The estimated lengths of
BamHI-NcoI-digested DNA fragments are indicated
at the sides in kilobases.
|
|
RCMV
R78c transcripts.
The deletion of the R78 ORF might
invoke unforeseen events such as disruption of unknown
promoter/enhancer regions of the neighboring gene R77, R79, or R80. To
investigate the effect of modification of the R78 genes on
transcription of these neighboring genes, a Northern blot hybridization
experiment was performed with poly(A)+ RNA from REF
infected with one of the two recombinant viruses (RCMV
R78c) and wt
RCMV-infected REF. The genes upstream and downstream of the R78 gene
were found to have considerable sequence similarity to the MCMV M77,
M79, and M80 genes (54), respectively (data not shown).
These RCMV genes are therefore referred to as R77, R79, and R80,
respectively. Probes were generated from R77-, R78-, R79-, R79/R80-,
and neo-specific DNA fragments (Fig. 6A and
B) and hybridized with
poly(A)+ RNA extracted from either mock-, RCMV-, or
RCMV
R78c-infected fibroblasts at 48 h p.i. (Fig. 6C).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 6.
Transcription of R78 and neighboring genes. The wt RCMV
(A) and RCMV R78c (B) genomes are represented by lines. ORFs are
indicated by white, hatched, and black arrow boxes, probes are
indicated by black boxes, and transcripts are indicated by black arrow
boxes below the genomes. Lengths are shown at the sides in kilobases.
(C) Autoluminographs from Northern blots that contain
poly(A)+ RNA from virus-infected REF. The transcript
lengths that correspond to the detected hybridization signals are
indicated in kilobases. M, mock infected; W, wt RCMV infected; ,
RCMV R78c infected.
|
|
In agreement with a previous Northern blot hybridization experiment
(Fig.
3), the R78-specific probe hybridized to three distinct
RCMV
transcripts of 1.8, 3.7, and albeit weakly, 5.7 kb, respectively
(Fig.
6C, lane 5). Our hypothesis that the larger two of these
R78-specific
transcripts also contained the R77 ORF was verified
by hybridization
with an R77-specific probe, which led to the
detection of similar 3.7- and 5.7-kb transcripts (lane 2). In
poly(A)
+ RNA from
RCMV

R78c-infected REF, the R77-specific probe and the
R78-specific
probe hybridized to similar transcripts. Interestingly,
these
transcripts are approximately 1 kb longer than their counterparts
from
wt RCMV-infected REF (lanes 3 and 6). These transcripts also
hybridized
to a
neo-specific probe (lane 15), indicating that
the
2.8-kb transcript (lanes 6 and 15) contains the modified R78
ORF as
well as
neo sequences, and both the 4.7-kb transcript (lanes
3, 6, and 15) and the 6.7-kb transcript (lanes 3, 6, and 15) encompass
R77, the modified R78 ORF, as well as
neo sequences (Fig.
6B).
Additionally, the
neo probe hybridized to a unique
1.2-kb transcript
(lane 15). A similar
neo-specific
transcript was previously found
to be expressed by an RCMV strain
(RCMV

R33) of which the R33
gene was disrupted by the
neo
gene (
9).
R79-specific transcripts were detected in neither wt RCMV- nor
RCMV

R78c-infected REF (Fig.
6C, lanes 8 and 9). This might
be a
consequence of either a low level of R79 transcription or
low
efficiency of labeling of the R79-specific probe that was
used for
hybridization. Thus, a larger probe specific for both
R79 and R80 was
derived from the 1088-bp
BglII-
SalI fragment from
plasmid p116 (Fig.
6A and B). With this probe, transcripts of
similar
lengths (2.4 kb) were detected in either RCMV- or RCMV

R78c-infected
REF (Fig.
6C, lanes 11 and 12). Since the lengths of these transcripts
correspond to the size of the R80 ORF (2,457 bp [
13]),
we hypothesize
that they contain R80 mRNA rather than R79 mRNA (Fig.
6A
and B).
Although we cannot formally exclude the possibility that
disruption
of the R78 ORF affects transcription of the R79 gene, we
hypothesize
that transcription of R79 does not differ between
RCMV and RCMV

R78c.
This hypothesis is based on the following two
observations. First,
the putative promoter of R79 is likely to be
situated upstream
of the R79 ORF, within the R80 ORF distant from the
disrupted
R78 site in RCMV

R78c. In addition, a potential
polyadenylation
site downstream of the R79 ORF and neighboring the R78
ORF (complementary
to nucleotides 1858 to 1863 of GenBank accession no.
AF077758)
is preserved in both RCMV

R78c and RCMV

R78a.
The R78 gene is important for efficient virus replication in
various cell types in vitro.
The replication characteristics of
RCMV, RCMV
R78a, and RCMV
R78c were assessed in four different cell
types: REF RHEC, RSMC, and R2M
. Cells were infected with either
RCMV, RCMV
R78a, or RCMV
R78c, and the proportion of infected cells
relative to the total population of cells was determined at various
time points. Additionally, the amount of excreted infectious virus was
determined for each cell type. As shown in Fig.
7, the infected cell ratios did not
differ significantly among REF and RSMC infected with either wt RCMV or
each of the recombinant viruses during the observed time course. Also,
infected cell ratios as well as virus titers in the culture medium of
RHEC and R2M
infected with either wt or recombinant virus did not
differ significantly (data not shown). However, clear differences were
observed in virus titers in the culture medium of virus-infected REF
and RSMC. In particular, at days 5 and 7 p.i., virus titers were
10- to 100-fold lower in the culture medium of both RCMV
R78a- and
RCMV
R78c-infected REF than in the culture medium of wt RCMV-infected
REF (Fig. 7). Additionally, at day 5 p.i., virus titers were
10-fold lower in the culture medium of recombinant virus-infected RSMC
than in the medium of wt virus-infected RSMC (Fig. 7). Taken together, these data suggest that (i) R78-deleted viruses enter cells and spread
throughout the monolayers of cells at similar rates as wt virus and
(ii) in REF and RSMC, the production of recombinant virus is less
efficient than the production of wt virus.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 7.
RCMV is attenuated upon deletion of the R78 gene. REF
were infected at an MOI of 0.01 with either wt RCMV ( ), RCMV R78a
( ), or RCMV R78c ( ). RSMC were infected with wt and mutant
virus at an MOI of 1 (relative to REF infection). The upper graphs show
the infected cell/total cell ratios at various time points p.i.; the
lower graphs show virus titers determined in culture medium up to 7 days p.i. Standard deviations are indicated by vertical bars.
|
|
RCMV
R78a and RCMV
R78c induce syncytium formation in REF.
In addition to the differences in virus replication between wt and
mutant viruses, the morphology of REF infected with either RCMV
R78a
or RCMV
R78c clearly contrasted with that of wt virus-infected REF.
Within the monolayers of mutant RCMV-infected REF (Fig. 8C and
D) but not in those of
infected RSMC, RHEC or R2M
, we observed syncytium-like cellular
cultures that were larger than those typically seen in wt RCMV-infected
REF monolayers (Fig. 8B). These structures appear 3 to 4 days p.i. To
investigate the nature of these structures more closely, they were
subjected to immunofluorescence staining and confocal laser scan
microscopy. To this purpose, virus-infected REF were stained with MAb
RCMV 8, which detects E-phase-expressed antigens in the nuclei
(20). Additionally, these cells were counterstained with
phalloidin, which binds to cytoskeletal F-actin fibers localized in the
cytoplasm. MAb RCMV 8 and phalloidin were labeled with fluorescent
markers fluorescein isothiocyanate and rhodamine, respectively.
Surprisingly, the large structures that were seen in either
RCMV
R78a- or RCMV
R78c-infected REF appeared to consist of a
single cytoplasmic entity encapsulating 2 to 20 distinct nuclei. A
typical example of such a syncytium-like structure is shown in Fig. 8E.
The significance of these polykaryotic cells, or syncytia, and their
relation to the function of the R78 gene is discussed below.


View larger version (277K):
[in this window]
[in a new window]
|
FIG. 8.
RCMV R78 deletion mutants induce syncytium formation in
vitro. Immunofluorescence micrographs (magnification of ×400) show
uninfected REF (A) and REF infected with either wt RCMV (B),
RCMV R78a (C), or RCMV R78c (D). (E) Confocal laser scan micrograph
taken from a syncytium structure in a monolayer of RCMV R78c-infected
REF. The scale bar indicates 20 µm. The left-hand frame shows
intracellular F-actin fibers that were stained with phalloidin-rhodamin
(Eugene, Leiden, The Netherlands); the right-hand frame, of the same
microscopic view, shows the nucleic distribution of RCMV E antigens
detected by MAb RCMV 8 plus anti-mouse-fluorescein isothiocyanate.
|
|
R78 has a critical function in the pathogenesis of RCMV infection
in vivo.
The role of R78 in the pathogenesis of RCMV disease was
investigated by infection of rats with either wt or mutant virus. To
compare virus dissemination in wt virus-infected and mutant virus-infected rats, two groups of immunocompromised rats were infected
with 5 × 106 PFU of either RCMV or RCMV
R78c. At
days 4 and 21 p.i., the presence of virus in internal organs
(aorta, heart, kidney, liver, lung, lymph nodes, pancreas, salivary
glands, spleen, and thymus) of the infected rats was determined. At day
4 p.i., virus could be detected in 18% of the aforementioned
organs in wt RCMV-infected rats and in 9% of the organs of
RCMV
R78c-infected rats, as determined by either plaque assay
or immunohistochemistry. At this time point, the highest virus titers
were found in the spleens of wt virus- or mutant virus-infected rats.
In contrast to the marked differences in replication efficiency between
wt and deletion mutant virus in vitro, the differences in the amount of
virus recovered from either spleen (Table 3) or other organs (not
shown) of infected rats were less dramatic. Neither wt nor mutant virus
could be detected in the liver, pancreas, and salivary glands at day
4 p.i. At day 21 p.i., virus could be recovered from salivary
glands of both wt RCMV- and RCMV
R78c-infected rats but not
from any of the other organs analyzed. Surprisingly, virus titers in
salivary glands did not differ significantly between RCMV- and
RCMV
R78c-infected rats (Table 3).
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Virus titers and immunohistochemical detection of RCMV
and RCMV R78c in salivary glands and spleen tissue
|
|
In a separate in vivo experiment, the virulence of wt and mutant
viruses was determined by infecting rats with potentially
lethal doses
of virus. To this purpose, three groups of 4-week-old
immunosuppressed
rats were infected with 10
6 PFU of either RCMV,
RCMV

R78a, or RCMV

R78c. Surprisingly, we
found that mortality was
dramatically lower in RCMV

R78a- and
RCMV

R78c-infected rats
than in RCMV-infected rats (Fig.
9). This
result indicates that R78 plays an important role in the pathogenesis
of RCMV infection.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 9.
The R78 gene plays a vital role in RCMV pathogenesis in
vivo. The graph indicates survival of three groups of immunocompromised
rats after intraperitoneal inoculation with 106 PFU of
either wt RCMV ( ), RCMV R78a ( ), or RCMV R78c ( ). Survival
was recorded up to day 28 p.i.
|
|
 |
DISCUSSION |
Herpesviruses are known for the large size and complexity of their
genomes, which encompass a vast number of genes, many of which are
homologous to genes of the host organism. Beta- and gammaherpesvirus
genomes contain genes homologous to GCR genes of the host. Eighteen
beta- and gammaherpesvirus-encoded GCR genes have been recognized to
date (4, 9, 21-23, 25, 33, 44, 49, 48, 54, 57, 63). These
genes can be arranged into four groups based on sequence homology,
genome location, and function of the respective gene product. One group
(the US28 family) consists of two GCR genes: US27 and US28
(23). Both are exclusively present within an unconserved
region of the HCMV genome (22). These GCRs are highly
similar to mammalian chemokine receptors (15, 30). Although
little is known about the function of the GCR encoded by US27, the HCMV
US28-encoded GCR is a well-studied example of a virus-encoded GCR with
an immunomodulatory function. This receptor was shown to bind
chemokines MIP1
, MIP1
, RANTES, MCP-1, and MCP-3 (14, 31,
47). Additionally, Bodaghi et al. reported that the US28 gene
product modifies the chemokine environment of HCMV-infected cells
through sequestering of
chemokines by continuous internalization
(15). A second group (the UL33 family) contains five GCR
genes: HCMV UL33 (23), RCMV R33 (9), MCMV M33
(26), and HHV-6 and -7 U12 (33, 49). Both
sequence and position of these genes within their respective genomes
are conserved. Similar to the US28 family, GCRs of the UL33 family were
shown to be related to chemokine receptors. Previously, we reported
that the predicted amino acid sequences of UL33-like receptors share
more similarity with mammalian chemokine receptors than with
nonchemokine receptors (9). Moreover, Isegawa et al.
(38) demonstrated that one member of the UL33 family of GCRs, HHV-6 U12, is a functional
-chemokine receptor capable of
binding MIP1
, MIP1
, RANTES, and MCP-1 (38). Although
not much is known about the function of this chemokine receptor-like family, Margulies et al. detected the UL33 protein in both the membranes of HCMV-infected cells and the envelopes of HCMV virions (43a). Additionally, both RCMV R33 and MCMV M33 genes were
shown to be essential for RCMV and MCMV replication in salivary glands of infected rats and mice, respectively (9, 26). A third group (the gammaherpesvirus GCR family) consists of seven
gammaherpesvirus-encoded chemokine receptor-like genes: Epstein-Barr
virus BILF1 (5, 25), HVS ECRF3 (48), KSHV ORF 74 (4), murine gammaherpesvirus 68 ORF 74 (63), and
equine herpesvirus E1, E6, and E8 (57). In contrast to GCR
genes of the US28 and UL33 family, sequences of the gammaherpesvirus
GCR family are less well conserved. However, like GCR genes of the US28
and UL33 family, they show significant similarity with mammalian
chemokine receptors (4, 26, 48, 57, 63). The role of any of
these GCRs in replication or persistence of gammaherpesviruses is
unknown. To date, two members of this family have been studied in
detail. The HVS ECRF3-encoded GCR was shown to be capable of binding
chemokines interleukin-8, GRO/MGSA, and NAP-2 (1).
Another gammaherpesvirus-encoded GCR, the KSHV ORF 74 gene product, was
demonstrated to bind both
(interleukin-8, MGSA, NAP-2, and PF-4)
and
(I-309 and RANTES) chemokines. In addition, the ORF 74 protein
was found to be constitutively active (4), having both
oncogenic and angiogenic potential (7). A fourth, novel
group of GCR genes (the UL78 family) comprises five betaherpesvirus
ORFs that were recently recognized as putative GCR genes: HCMV UL78,
RCMV R78, MCMV M78, and HHV-6 and -7 U51 (references 33,
49, and 54 and this report). Similar to the positions of GCR genes of the UL33 family, the positions of the
UL78-like genes are conserved within betaherpesvirus genomes. However,
in contrast to the sequences of the UL33-like genes, the sequences of
the UL78 family are poorly conserved. The predicted amino acid
sequences derived from the UL78-like genes significantly resemble
neither chemokine receptors nor any other of the thousands of GCRs
currently known. The assumption that UL78-like genes are GCRs is based
on three characteristics: (i) the presence of seven hydrophobic regions
within the predicted amino acid sequences derived from all UL78-like
genes (53); (ii) the presence of two cysteine residues
within these amino acid sequences, which might be required for correct
folding of the GCR polypeptide (53); and (iii) a stretch of
amino acids within these amino acid sequences which bears similarity to
a domain known to be required for G protein coupling (53).
Consequently, the UL78 family is a novel class of orphan GCRs encoded
by betaherpesviruses.
To investigate the role of the R78 gene in virus replication, RCMV
strains in which the R78 gene is disrupted were constructed. These R78
deletion mutant strains were found to replicate 10- to 100-fold less
efficiently than wt RCMV in fibroblasts and smooth muscle cells in
vitro. By contrast, RCMV and MCMV strains that carry a deletion of the
R33 and M33 gene, respectively, were previously found to replicate in
vitro with efficiencies similar to those of the corresponding wt
viruses (9, 26). A difference between these mutants and the
R78 deletion mutants was also seen in vivo: both R33 and M33 deletion
mutants were found to be impaired in replication in salivary glands of
infected animals, whereas R78 deletion mutants were demonstrated to
replicate as efficiently as wt RCMV in salivary glands. It is therefore
likely that although both R33 and R78 putatively encode GCRs, these
genes exert unrelated functions.
A lower efficiency of virus replication in vitro was observed not only
after deletion of the complete R78 ORF from the RCMV genome but also
after deletion of the region that encodes the putative R78 GCR C
terminus. This putative intracellular part of the protein is therefore
likely to be essential for the function of the R78 protein. The C
terminus, like the DRL motif in the second intracellular domain of the
R78 protein, might be essential for G protein coupling and signal
transduction, similar to what was found for other GCRs (53).
The RCMV R78 gene plays an important part in the pathogenesis of virus
infection in vivo. This was inferred from the lower mortality seen
among immunocompromised rats infected with either RCMV
R78a or
RCMV
R78c than among animals infected with wt virus. Although we did
not find significant differences in virus replication between
recombinant and wt viruses in vivo, it is possible that the decrease in
virulence that is seen after disruption of the R78 gene of RCMV is
correlated with the observation that both RCMV
R78a and RCMV
R78c
replicate less efficiently in fibroblasts and smooth muscle cells in
vitro than wt virus. Similar to the R78 gene, the R33 GCR-like gene was
reported to have a vital function in the pathogenesis of RCMV infection
(9). It is likely that the HCMV counterparts of these genes
(UL78 and UL33, respectively) have similar, important functions in the
pathogenesis of HCMV infections in humans. The gene products of both
UL78 and UL33 can therefore be considered as potential targets for
future development of novel antiviral strategies.
The two recombinant RCMV strains described in this report induce
syncytium formation in infected fibroblasts in vitro. Previously, syncytium formation has been observed in many different cell types infected with a variety of herpesvirus species: HCMV-infected human
amnion cells (28), varicella-zoster virus-infected human melanoma cells (34), Epstein-Barr virus-superinfected Raji
cells (8), HHV-6-infected human primary fetal astrocytes
(35), HHV-7-infected T lymphocytes (56), and
RCMV-infected Rat2 cells (11). In these cases, syncytium
formation appears to be associated with the cell type or MOI, since the
same virus strains fail to produce these syncytium (syn)
phenotypes upon infection of other permissive cell lines (8, 28,
34, 35) or after infection at lower titers (8, 56).
Well-defined syn loci were found within genomes of a limited
number of herpesvirus species, in particular within the genomes of
herpes simplex type 1 (HSV-1) strains: UL20 (6), UL24
(40), UL27-gB (29), and UL53-gK (37).
Some HCMV genes were likewise associated with syncytium formation.
Syncytia are produced in human glioblastoma cells that constitutively
express HCMV UL55-gB (59). Additionally, the chemokine
receptor encoded by HCMV US28 was shown to enhance cell-cell fusion in
cells constitutively expressing retroviral envelope glycoproteins
(52). The recombinant RCMV strains RCMV
R78a and RCMV
R78c are the first syn mutant CMVs reported. We
postulate that functional R78-encoded GCRs transduce signals to the
cellular interior, thereby creating an intracellular environment
essential for the formation of protein complexes to establish
intercellular junctions. In HCMV- and HSV-1-infected cells, these
cell-to-cell junctions are basically composed of viral glycoproteins
(27, 36, 43). Since many syn mutations are
localized in HSV glycoprotein genes (29, 37), syncytia could
be generated as a result of destabilized cell-to-cell contacts. The
putative GCR encoded by R78 may mediate stabilization of glycoprotein
complexes, directly by association with these glycoprotein complexes,
or indirectly, through signal transduction to establish cell-to-cell
contacts. These possible mechanisms for the function of the R78 gene
product will have to be addressed in future studies.
 |
ACKNOWLEDGMENTS |
We thank Erik Beuken for cloning and sequencing of RCMV DNA. We
also thank Joanne van Dam, Suzanne Kaptein, and Marjorie Nelissen for
processing rat organs, Jos Broers for generating the confocal laser
scan micrographs, and Rien Blok for critically reading the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Microbiology, Maastricht University, P.O. Box 5800, 6202 AZ
Maastricht, The Netherlands. Phone: 31 43 3876669. Fax: 31 43 3876643. E-mail: kvi{at}lmib.azm.nl.
 |
REFERENCES |
| 1.
|
Ahuja, S. K., and P. M. Murphy.
1993.
Molecular piracy of mammalian interleukin-8 receptor type B by herpesvirus saimiri.
J. Biol. Chem.
268:20691-20694[Abstract/Free Full Text].
|
| 2.
| ALIGN Query. 1 January 1997, posting date.
[Online.] ALIGN program. Genestream, Institut de
Génétique Humaine, Montpellier, France.
http://www2.igh.cnrs.fr/bin/align-guess.cgi. [11 January
1999, last date accessed.]
|
| 3.
|
An, S.,
T. Bleu,
O. G. Hallmark, and E. J. Goetzl.
1998.
Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid.
J. Biol. Chem.
273:7906-7910[Abstract/Free Full Text].
|
| 4.
|
Arvanitakis, L.,
E. Geras-Raaka,
A. Varma,
M. C. Gershengorn, and E. Cesarman.
1997.
Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation.
Nature
385:347-350[Medline].
|
| 5.
|
Baer, R. J.,
A. T. Bankier,
M. D. Biggin,
P. L. Deininger,
P. J. Farrell,
T. J. Gibson,
G. F. Hatful,
G. S. Hudson,
S. C. Satchwell,
C. Sequin,
P. S. Tuffnell, and B. G. Barrell.
1984.
DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
Nature
310:207-211[Medline].
|
| 6.
|
Baines, J. D.,
P. L. Ward,
G. Campadelli-Fiume, and B. Roizman.
1991.
The UL20 gene of herpes simplex virus 1 encodes a function necessary for viral egress.
J. Virol.
65:6414-6424[Abstract/Free Full Text].
|
| 7.
|
Bais, C.,
B. Santomasso,
O. Coso,
L. Arvanitakis,
E. Geras Raaka,
J. S. Gutkind,
A. S. Asch,
E. Cesarman,
M. C. Gerhengorn, and E. A. Mesri.
1998.
G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Nature
391:86-89[Medline].
|
| 8.
|
Bayliss, G. J., and H. Wolf.
1981.
An Epstein-Barr virus early protein induces cell fusion.
Proc. Natl. Acad. Sci. USA
78:7162-7165[Abstract/Free Full Text].
|
| 9.
|
Beisser, P. S.,
C. Vink,
J. G. van Dam,
G. Grauls,
S. J. Vanherle, and C. A. Bruggeman.
1998.
The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection.
J. Virol.
72:2352-2363[Abstract/Free Full Text].
|
| 10.
|
Beisser, P. S.,
S. J. F. Kaptein,
E. Beuken,
C. A. Bruggeman, and C. Vink.
1998.
The Maastricht strain and England strain of rat cytomegalovirus represent different betaherpesvirus species rather than strains.
Virology
245:341-351.
|
| 11.
| Beisser, P. S., C. A. Bruggeman, and C. Vink. Unpublished data.
|
| 12.
|
Beuken, E.,
R. Slobbe,
C. A. Bruggeman, and C. Vink.
1996.
Cloning and sequence analysis of the genes encoding DNA polymerase, glycoprotein B, ICP 18.5 and major DNA-binding protein of rat cytomegalovirus.
J. Gen. Virol.
77:1559-1562[Abstract/Free Full Text].
|
| 13.
| Beuken, E., C. A. Bruggeman, and C. Vink.
Unpublished data.
|
| 14.
|
Billstrom, M. A.,
G. L. Johnson,
N. J. Avdi, and G. S. Scott Worthen.
1998.
Intracellular signalling by the chemokine receptor US28 during human cytomegalovirus infection.
J. Virol.
72:5535-5544[Abstract/Free Full Text].
|
| 15.
|
Bodaghi, B.,
T. R. Jones,
D. Zipeto,
C. Vita,
L. Sun,
L. Laurent,
F. Arenzana-Seisdedos,
J. Virelizier, and S. Michelson.
1998.
Chemokine sequenstration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells.
J. Exp. Med.
188:855-866[Abstract/Free Full Text].
|
| 16.
|
Brown, T.
1993.
Analysis of DNA sequences by blotting and hybridization, p. 4.2.1-4.2.15.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
|
| 17.
|
Brown, T., and K. Mackey.
1997.
Analysis of RNA by Northern and slot blot hybridization, p. 4.9.1-4.9.16.
In
F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
|
| 18.
|
Bruggeman, C. A.,
H. Meijer,
P. H. J. Dormans,
W. H. M. Debie,
G. E. L. M. Grauls, and C. P. A. van Boven.
1982.
Isolation of a cytomegalovirus-like agent from wild rats.
Arch. Virol.
73:231-241[Medline].
|
| 19.
|
Bruggeman, C. A.,
H. Meijer,
F. Bosman, and C. P. A. van Boven.
1985.
Biology of rat cytomegalovirus infection.
Intervirology
24:1-9[Medline].
|
| 20.
|
Bruning, J.,
W. H. M. Debie,
P. H. J. Dormans,
H. Meijer, and C. A. Bruggeman.
1987.
The development and characterization of monoclonal antibodies against rat cytomegalovirus induced agents.
Arch. Virol.
94:55-70[Medline].
|
| 21.
|
Cao, J. X.,
P. D. Gershon, and D. N. Black.
1995.
Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G-protein-coupled chemokine receptor homologue.
Virology
209:207-212[Medline].
|
| 22.
|
Chee, M. S.,
A. T. Bankier,
S. Beck,
R. Bohni,
C. M. Brown,
R. Cerny,
T. Horsnell,
C. A. Hutchison III,
T. Kouzarides,
J. A. Martignetti,
E. Preddie,
S. C. Satchwell,
P. Tomlinson,
K. M. Weston, and B. G. Barrell.
1990.
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.
Curr. Top. Microbiol. Immunol.
154:125-169[Medline].
|
| 23.
|
Chee, M. S.,
S. C. Satchwell,
E. Preddie,
K. M. Weston, and B. G. Barrell.
1990.
Human cytomegalovirus encodes three G protein-coupled receptor homologues.
Nature
344:774-777[Medline].
|
| 24.
|
Damoiseaux, J. G. M. C.,
E. A. Döpp,
W. Calame,
D. Chao,
G. G. MacPherson, and C. D. Dijkstra.
1994.
Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1.
Immunology
83:140-147[Medline].
|
| 25.
|
Davis-Poynter, N. J., and H. E. Farrell.
1996.
Masters of deception: a review of herpesvirus immune evation strategies.
Immunol. Cell Biol.
74:513-522[Medline].
|
| 26.
|
Davis-Poynter, N. J.,
D. M. Lynch,
H. Vally,
G. R. Shellam,
W. D. Rawlinson,
B. G. Barrell, and H. E. Farrell.
1997.
Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus.
J. Virol.
71:1521-1529[Abstract].
|
| 27.
|
Dingwell, K. S.,
C. R. Brunetti,
R. L. Hendricks,
Q. Tang,
M. Tang,
A. J. Rainbow, and D. C. Johnson.
1994.
Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells.
J. Virol.
68:834-845[Abstract/Free Full Text].
|
| 28.
|
Figueroa, M. E.,
L. Geder, and F. Rapp.
1978.
Infection of human amnion cells with cytomegalovirus.
J. Med. Virol.
2:369-375[Medline].
|
| 29.
|
Gage, P. J.,
M. Levine, and J. C. Glorioso.
1993.
Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B.
J. Virol.
67:2191-2201[Abstract/Free Full Text].
|
| 30.
|
Gao, J. L., and P. M. Murphy.
1994.
Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor.
J. Biol. Chem.
269:28539-28542[Abstract/Free Full Text].
|
| 31.
|
Gao, J. L.,
D. B. Kuhns,
H. L. Tiffany,
D. McDermott,
X. Li,
U. Franke, and P. M. Murphy.
1993.
Structure and functional expression of the human macrophage inflammatory protein 1 /RANTES receptor.
J. Exp. Med.
177:1421-1427[Abstract/Free Full Text].
|
| 32.
|
Gerszten, R. E.,
J. Chen,
M. Ishii,
K. Ishii,
T. Nanevicz,
C. W. Turck,
T. H. Vu, and S. R. Coughlin.
1994.
Thrombin receptor's specificity for agonist peptide is determined by its extracellular surface.
Nature
368:648-651[Medline].
|
| 33.
|
Gompels, U. A.,
J. Nicholas,
G. Lawrence,
M. Jones,
B. J. Thomson,
M. E. Martin,
S. Efstathiou,
M. Craxton, and H. A. Macaulay.
1995.
The DNA sequence of human herpesvirus-6: structure, coding content and genome evolution.
Virology
209:29-51[Medline].
|
| 34.
|
Harson, R., and C. Grose.
1995.
Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte.
J. Virol.
69:4994-5010[Abstract].
|
| 35.
|
He, J.,
M. McCarthy,
Y. Zhou,
B. Chandran, and C. Wood.
1996.
Infection of primary human fetal astrocytes by human herpesvirus 6.
J. Virol.
70:1296-1300[Abstract].
|
| 36.
|
Huber, M. T., and T. Compton.
1998.
The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex.
J. Virol.
72:8191-8197[Abstract/Free Full Text].
|
| 37.
|
Hutchinson, L.,
K. Goldsmith,
D. Snoddy,
H. Ghosh,
F. L. Graham, and D. C. Johnson.
1992.
Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusion.
J. Virol.
66:5603-5609[Abstract/Free Full Text].
|
| 38.
|
Isegawa, Y.,
Z. Ping,
K. Nakano,
N. Sugimoto, and K. Yamanishi.
1998.
Human herpesvirus 9 open reading frame U12 encodes a functional -chemokine receptor.
J. Virol.
72:6104-6112[Abstract/Free Full Text].
|
| 39.
| ISREC WU-BLAST server. 3 June 1999, revision date.
[Online.] BLAST program, version 2.0. ISREC Bioinformatics
Group, Swiss Institute of Bioinformatics, Geneva, Switzerland.
http://www.ch.embnet.org/software/WUBLAST_form.html.
[11 January 1999, last date accessed.]
|
| 40.
|
Jacobson, J. G.,
S. L. Martin, and D. M. Coen.
1989.
A conserved open reading frame that overlaps the herpes simplex virus thymidine kinase gene is important for viral growth in cell culture.
J. Virol.
63:1839-1843[Abstract/Free Full Text].
|
| 41.
|
Kozak, M.
1987.
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.
Nucleic Acids Res.
15:8125-8148[Abstract/Free Full Text].
|
| 42.
|
Kuhn, D. E.,
C. J. Beall, and P. E. Kolattukudy.
1995.
The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity.
Biochem. Biophys. Res. Commun.
211:325-330[Medline].
|
| 43.
|
Laquerre, S.,
R. Argnani,
D. B. Anderson,
S. Zucchini,
R. Manservigi, and J. C. Glorioso.
1998.
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread.
J. Virol.
72:6119-6130[Abstract/Free Full Text].
|
| 43a.
|
Margulies, B. J.,
H. Browne, and W. Gibson.
1996.
Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles.
Virology
225:111-125[Medline].
|
| 44.
|
Massung, R. F.,
V. Jayarama, and R. W. Moyer.
1993.
DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue.
Virology
197:511-528[Medline].
|
| 45.
|
Meijer, H.,
J. C. Dreesen, and C. P. van Boven.
1986.
Molecular cloning and restriction endonuclease mapping of the rat cytomegalovirus genome.
J. Gen. Virol.
67:1327-1342[Abstract/Free Full Text].
|
| 46.
|
Myers, E. W., and W. Miller.
1988.
Optimal alignments in linear space.
Comput. Appl. Biosci.
4:11-17[Abstract/Free Full Text].
|
| 47.
|
Neote, K.,
D. DiGregorio,
J. Y. Mak,
R. Horuk, and T. J. Schall.
1993.
Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor.
Cell
72:415-425[Medline].
|
| 48.
|
Nicholas, J.,
K. R. Cameron, and R. W. Honess.
1992.
Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins.
Nature
355:362-365[Medline].
|
| 49.
|
Nicholas, J.
1996.
Determination and analysis of the complete nucleotide sequence of human herpesvirus 7.
J. Virol.
70:5975-5989[Abstract].
|
| 50.
|
Orlandi, A.,
H. Paul Ehrlich,
P. Ropraz,
L. G. Spagnioli, and G. Gabbiani.
1994.
Rat aortic smooth muscle cells isolated from different layers and different times after endothelial denudation show distinct biological features in vitro.
Arterioscler. Thromb.
14:982-989[Abstract/Free Full Text].
|
| 51.
|
Parente, M. G.,
L. C. Chung,
J. Ryynanen,
D. T. Woodley,
K. W. Wynn,
E. A. Bauer,
M. G. Mattei,
M.-L. Chu, and J. Uitto.
1991.
Human type VII collagen: cDNA cloning and chromosomal mapping of the gene.
Proc. Natl. Acad. Sci. USA
88:6931-6935[Abstract/Free Full Text].
|
| 52.
|
Pleskoff, O.,
C. Tréboute, and M. Alizon.
1998.
The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins.
J. Virol.
72:6389-6397[Abstract/Free Full Text].
|
| 53.
|
Probst, W. C.,
L. A. Snyder,
D. I. Schuster,
J. Brosius, and S. C. Sealfon.
1992.
Sequence alignment of the G-protein coupled receptor superfamily.
DNA Cell Biol.
11:1-20[Medline].
|
| 54.
|
Rawlinson, W. D.,
H. E. Farrell, and B. G. Barrell.
1996.
Analysis of the complete DNA sequence of murine cytomegalovirus.
J. Virol.
70:8833-8849[Abstract].
|
| 55.
|
Stals, F. S.,
F. Bosman,
C. P. van Boven, and C. A. Bruggeman.
1990.
An animal model for therapeutic intervention studies of CMV infection in the immunocompromised host.
Arch. Virol.
114:91-107[Medline].
|
| 56.
|
Secchiero, P.,
Z. N. Berneman,
R. C. Gallo, and P. Lusso.
1994.
Biological and molecular characteristics of human herpesvirus 7: in vitro growth optimalization and development of a syncytia inhibition test.
Virology
202:506-512[Medline].
|
| 57.
|
Telford, E. A.,
M. S. Watson,
H. C. Aird,
J. Perry, and A. J. Davison.
1995.
The DNA sequence of equine herpesvirus 2.
J. Mol. Biol.
249:520-528[Medline].
|
| 58.
| TMpred Prediction of Transmembrane Regions and
Orientation. 3 June 1999, revision date. [Online.] TMpred
program. ISREC Bioinformatics Group, Swiss Institute of Bioinformatics,
Geneva, Switzerland.
http://www.ch.embnet.org/software/TMPRED_form.html. [11 January
1999, last date accessed.]
|
| 59.
|
Tugizov, S.,
Y. Wang,
I. Qadri,
D. Navarro,
E. Maidji, and L. Pereira.
1995.
Mutated forms of human cytomegalovirus glycoprotein B are impaired in inducing syncytium formation.
Virology
209:580-591[Medline].
|
| 60.
|
Vossen, R. C. R. M.,
J. G. Derhaag,
M. E. P. Slobbe-van Drunen,
A. M. Duijvestijn,
M. C. E. van Dam-Mieras, and C. A. Bruggeman.
1996.
A dual role for endothelial cells in cytomegalovirus infection? A study of cytomegalovirus infection in a series of rat endothelial cell lines.
Virus Res.
46:65-74[Medline].
|
| 61.
|
Vink, C.,
E. Beuken, and C. A. Bruggeman.
1996.
Structure of the rat cytomegalovirus genome termini.
J. Virol.
70:5221-5229[Abstract/Free Full Text].
|
| 62.
| Vink, C., E. Beuken, and C. A. Bruggeman.
Unpublished results.
|
| 63.
|
Virgin, H. W., IV,
P. Latreille,
P. Wamsley,
K. Hallsworth,
K. E. Weck,
A. J. Dal Canto, and S. H. Speck.
1997.
Complete sequence and genomic analysis of murine gammaherpesvirus 68.
J. Virol.
71:5894-5904[Abstract].
|
| 64.
|
Wilson, R.,
R. Ainscough,
K. Anderson,
C. Baynes,
M. Berks,
J. Bonfield,
J. Burton,
M. Connell,
T. Copsey,
J. Cooper,
A. Coulson,
M. Craxton,
S. Dear,
Z. Du,
R. Durbin,
A. Favello,
L. Fulton,
A. Gardner,
P. Green,
T. Hawkins,
L. Hillier,
M. Jier,
L. Johnston,
M. Jones,
J. Kershaw,
J. Kirsten,
N. Laister,
P. Latreille,
J. Lightning,
C. Lloyd,
A. McMurray,
B. Mortimore,
M. O'Callaghan,
J. Parsons,
C. Percy,
L. Rifken,
A. Roopra,
D. Saunders,
R. Shownkeen,
N. Smaldon,
A. Smith,
E. Sonnhammer,
R. Staden,
J. Sulston,
J. Thierry-Mieg,
K. Thomas,
M. Vaudin,
K. Vaughan,
R. Waterston,
A. Watson,
L. Weinstock,
J. Wilkinson-Sproat, and P. Wohldman.
1994.
2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans.
Nature
368:32-38[Medline].
|
| 65.
|
Xu, M., and R. V. Lewis.
1990.
Structure of a protein superfiber: spider dragline silk.
Proc. Natl. Acad. Sci. USA
87:7120-7124[Abstract/Free Full Text].
|
| 66.
|
Yasuda, K.,
K. Raynor,
H. Kong,
C. D. Breder,
J. Takeda,
T. Reisine, and G. I. Bell.
1993.
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.
Proc. Natl. Acad. Sci. USA
90:6736-6740[Abstract/Free Full Text].
|
Journal of Virology, September 1999, p. 7218-7230, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sharp, E. L., Davis-Poynter, N. J., Farrell, H. E.
(2009). Analysis of the subcellular trafficking properties of murine cytomegalovirus M78, a 7 transmembrane receptor homologue. J. Gen. Virol.
90: 59-68
[Abstract]
[Full Text]
-
Sharp, E. L., Farrell, H. E., Borchers, K., Holmes, E. C., Davis-Poynter, N. J.
(2007). Sequence analysis of the equid herpesvirus 2 chemokine receptor homologues E1, ORF74 and E6 demonstrates high sequence divergence between field isolates. J. Gen. Virol.
88: 2450-2462
[Abstract]
[Full Text]
-
Tadagaki, K., Yamanishi, K., Mori, Y.
(2007). Reciprocal roles of cellular chemokine receptors and human herpesvirus 7-encoded chemokine receptors, U12 and U51. J. Gen. Virol.
88: 1423-1428
[Abstract]
[Full Text]
-
Fitzsimons, C. P., Gompels, U. A., Verzijl, D., Vischer, H. F., Mattick, C., Leurs, R., Smit, M. J.
(2006). Chemokine-Directed Trafficking of Receptor Stimulus to Different G Proteins: Selective Inducible and Constitutive Signaling by Human Herpesvirus 6-Encoded Chemokine Receptor U51. Mol. Pharmacol.
69: 888-898
[Abstract]
[Full Text]
-
Zhen, Z., Bradel-Tretheway, B., Sumagin, S., Bidlack, J. M., Dewhurst, S.
(2005). The Human Herpesvirus 6 G Protein-Coupled Receptor Homolog U51 Positively Regulates Virus Replication and Enhances Cell-Cell Fusion In Vitro. J. Virol.
79: 11914-11924
[Abstract]
[Full Text]
-
Tadagaki, K., Nakano, K., Yamanishi, K.
(2005). Human Herpesvirus 7 Open Reading Frames U12 and U51 Encode Functional {beta}-Chemokine Receptors. J. Virol.
79: 7068-7076
[Abstract]
[Full Text]
-
Michel, D., Milotic, I., Wagner, M., Vaida, B., Holl, J., Ansorge, R., Mertens, T.
(2005). The human cytomegalovirus UL78 gene is highly conserved among clinical isolates, but is dispensable for replication in fibroblasts and a renal artery organ-culture system. J. Gen. Virol.
86: 297-306
[Abstract]
[Full Text]
-
Paulsen, S. J., Rosenkilde, M. M., Eugen-Olsen, J., Kledal, T. N.
(2005). Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor. J. Virol.
79: 536-546
[Abstract]
[Full Text]
-
van Cleef, K. W. R., Scaf, W. M. A., Maes, K., Kaptein, S. J. F., Beuken, E., Beisser, P. S., Stassen, F. R. M., Grauls, G. E. L. M., Bruggeman, C. A., Vink, C.
(2004). The rat cytomegalovirus homologue of parvoviral rep genes, r127, encodes a nuclear protein with single- and double-stranded DNA-binding activity that is dispensable for virus replication. J. Gen. Virol.
85: 2001-2013
[Abstract]
[Full Text]
-
Gruijthuijsen, Y. K., Beuken, E. V. H., Smit, M. J., Leurs, R., Bruggeman, C. A., Vink, C.
(2004). Mutational analysis of the R33-encoded G protein-coupled receptor of rat cytomegalovirus: identification of amino acid residues critical for cellular localization and ligand-independent signalling. J. Gen. Virol.
85: 897-909
[Abstract]
[Full Text]
-
Liu, C., Sandford, G., Fei, G., Nicholas, J.
(2004). G{alpha} Protein Selectivity Determinant Specified by a Viral Chemokine Receptor-Conserved Region in the C Tail of the Human Herpesvirus 8 G Protein-Coupled Receptor. J. Virol.
78: 2460-2471
[Abstract]
[Full Text]
-
Casarosa, P., Gruijthuijsen, Y. K., Michel, D., Beisser, P. S., Holl, J., Fitzsimons, C. P., Verzijl, D., Bruggeman, C. A., Mertens, T., Leurs, R., Vink, C., Smit, M. J.
(2003). Constitutive Signaling of the Human Cytomegalovirus-encoded Receptor UL33 Differs from That of Its Rat Cytomegalovirus Homolog R33 by Promiscuous Activation of G Proteins of the Gq, Gi, and Gs Classes. J. Biol. Chem.
278: 50010-50023
[Abstract]
[Full Text]
-
Kaptein, S. J. F., Beisser, P. S., Gruijthuijsen, Y. K., Savelkouls, K. G. M., van Cleef, K. W. R., Beuken, E., Grauls, G. E. L. M., Bruggeman, C. A., Vink, C.
(2003). The rat cytomegalovirus R78 G protein-coupled receptor gene is required for production of infectious virus in the spleen. J. Gen. Virol.
84: 2517-2530
[Abstract]
[Full Text]
-
Lee, B. J., Koszinowski, U. H., Sarawar, S. R., Adler, H.
(2003). A Gammaherpesvirus G Protein-Coupled Receptor Homologue Is Required for Increased Viral Replication in Response to Chemokines and Efficient Reactivation from Latency. J. Immunol.
170: 243-251
[Abstract]
[Full Text]
-
Waldhoer, M., Kledal, T. N., Farrell, H., Schwartz, T. W.
(2002). Murine Cytomegalovirus (CMV) M33 and Human CMV US28 Receptors Exhibit Similar Constitutive Signaling Activities. J. Virol.
76: 8161-8168
[Abstract]
[Full Text]
-
Gruijthuijsen, Y. K., Casarosa, P., Kaptein, S. J. F., Broers, J. L. V., Leurs, R., Bruggeman, C. A., Smit, M. J., Vink, C.
(2002). The Rat Cytomegalovirus R33-Encoded G Protein-Coupled Receptor Signals in a Constitutive Fashion. J. Virol.
76: 1328-1338
[Abstract]
[Full Text]
-
Oliveira, S. A., Shenk, T. E.
(2001). Murine cytomegalovirus M78 protein, a G protein-coupled receptor homologue, is a constituent of the virion and facilitates accumulation of immediate-early viral mRNA. Proc. Natl. Acad. Sci. USA
98: 3237-3242
[Abstract]
[Full Text]
-
Vink, C., Beuken, E., Bruggeman, C. A.
(2000). Complete DNA Sequence of the Rat Cytomegalovirus Genome. J. Virol.
74: 7656-7665
[Abstract]
[Full Text]
-
Afonso, C. L., Tulman, E. R., Lu, Z., Zsak, L., Kutish, G. F., Rock, D. L.
(2000). The Genome of Fowlpox Virus. J. Virol.
74: 3815-3831
[Abstract]
[Full Text]
-
Beisser, P. S., Kloover, J. S., Grauls, G. E. L. M., Blok, M. J., Bruggeman, C. A., Vink, C.
(2000). The r144 Major Histocompatibility Complex Class I-Like Gene of Rat Cytomegalovirus Is Dispensable for both Acute and Long-Term Infection in the Immunocompromised Host. J. Virol.
74: 1045-1050
[Abstract]
[Full Text]